A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Protagenic Therapeutics Inc’s current trading price is -60.96% away from its 52-week high, while its distance from the 52-week low is 48.98%. The stock’s price range for this time frame has been between $0.49 and $1.87. The trading volume of the company’s shares in the Healthcare reached around 2.05 million for the day, which was evidently higher than the average daily volume of 0.31 million over the last three months.
Protagenic Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $1.87 on 05/22/24, and the lowest price during the same period was recorded at $0.49 on 10/11/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Protagenic Therapeutics Inc (PTIX) has experienced a quarterly rise of 21.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.96M and boasts a workforce of 3 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6617, with a change in price of -0.1230. Similarly, Protagenic Therapeutics Inc recorded 227,261 in trading volume during the last 100 days, posting a change of -14.42%.
How PTIX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PTIX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
PTIX Stock Stochastic Average
Protagenic Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 40.00%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 36.74%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 27.14% and 21.38%, respectively.
PTIX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -26.26%. However, over the last six months, the performance has been stronger by -52.75%. The price of PTIX increased 30.33% over the last 30 days. And in the last five days, it has surged by 25.67%.
